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Background: Previous studies have mainly focused on patient delay or D2N/D2B time when evaluating the impact of delayed reperfusion on 
mortality in ST-elevation myocardial infarction (STEMI). System delay, i.e. the time period from the patients first alert of the health care system to 
initiation of reperfusion therapy, might be a better performance measure. The aim of the present study was to compare door-to-needle/balloon 
(D2N/D2B) time and system delay, and evaluate their association to 30-day and long-term mortality.
Methods: We randomized 1572 patients to primary angioplasty (pPCI) or fibrinolysis. Mortality data was obtained from Danish registries. Study 
endpoints were 30-day mortality and long-term mortality.
Results: The mean follow-up time was 7.8 years (range 6.5 to 10.2 years). System delay was associated to 30-day mortality, (fibrinolysis: adjusted 
hazard ratio (HR) for every 30 min delay = 1.06, 95% Confidence Interval (CI) 0.97 - 1.15; pPCI: adjusted HR for every 30 min delay = 1.12, 95% CI 
1.00 - 1.26). Significance was lost at late follow-up, (fibrinolysis: adjusted HR for every 30 min delay = 1.02, 95% CI 0.97 - 1.07; pPCI: adjusted HR 
for every 30 min delay = 1.02, 95% CI 0.95 - 1.09). D2N/D2B did not predict 30-day or long-term mortality.
Conclusions: System delay constitutes the cumulated delay in reperfusion that is modifiable by the health care system. It predicts 30-day 
mortality after pPCI and is potentially a better marker for quality of care than D2N/D2B. System delay is proposed as the ideal performance 
measure when optimizing triage of STEMI-patients.
